AHHL is primarily engaged in nursing care, in home primary care, physiotherapy at home, sample collection, post-operative/post-surgical care
US FDA approval based on NEURO-TTRansform Phase III results
If approved, patritumab deruxtecan would be a first-in-class HER3 directed DXd antibody drug conjugate for these patients
The agreement grants Brinter the distribution rights of GrowInk bioinks in many countries
The bioprocess business will continue to pioneer contributions to safety and productivity in the manufacture of biotherapeutics
Sitagliptin Tablets USP, 25 mg, 50 mg, and 100 mg are indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus
The products are slated to be manufactured at the Ankleshwar facility and is expected to start contributing meaningfully to the revenue from FY25
Fischer Chemic will make an entry into the growing market of diagnostic imaging industry with innovative and disruptive technologies
Laurus Synthesis receives Form 483 with 5 observations from USFDA
Expansion of presence in India with electrical safety, electromagnetic compatibility and medical device biocompatibility, toxicity and microbiology testing and certification services
Subscribe To Our Newsletter & Stay Updated
